Neurocrine Biosciences (NBIX) Stock
Neurocrine Biosciences (NBIX) closed at $167.40 on Nov 13, 2026; its Tenet Score is 59 of 100 against 409 Healthcare peers.
7 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $167.40
- Nov 13, 2026
- Market cap
- $16.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 25.1×
- price ÷ earnings
- 52-week range
- 122.14 – 186.12
- low → high
- Tenet Score
- 59/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Neurocrine Biosciences, Inc. scores 59/100. Mixed. Strongest on quality and growth, financial health is the soft spot, trading at 25× earnings versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✕ Piotroski F-Score
- ✓ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
13F flows & insider trades land here.
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroid…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Incyte Corp.INCY | 64 | $24.7B |
| Viatris IncVTRS | 39 | $23.9B |
| Alnylam Pharmaceuticals IncALNY | 59 | $22.1B |
| Medpace Holdings IncMEDP | 57 | $18.3B |
| Exelixis IncEXEL | 71 | $17.1B |
| Ascendis Pharma A/SASND | 54 | $17.1B |
| Jazz Pharmaceuticals plcJAZZ | 43 | $15.5B |
| Elanco Animal Health IncELAN | 38 | $13.4B |
| Bio-Techne CorpTECH | 53 | $11.4B |
| Halozyme Therapeutics Inc.HALO | 68 | $11.4B |
Common questions
What sector and industry is Neurocrine Biosciences in?
Neurocrine Biosciences is in the Healthcare sector and the Drugs industry.
What is Neurocrine Biosciences' Tenet Score?
Neurocrine Biosciences' Tenet Score is 59 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




